Background
HIV – one of the world's deadliest infectious disease killers –
needs no introduction. It has killed almost 10 million people over
the last 10 years.
What makes these facts even more worrisome is that
there are effective treatments available and there is no
reason anyone should die from HIV. Sadly, in emerging economies
where HIV can have a prevalence rate in the range 3 to 20% of the
population, up to 30% of adults and 40% of children who are HIV
positive do not take their medications. There are 38.4 million
people living with HIV, 70% in Africa. Kenya
has one of the world's largest populations of people living with
HIV/AIDs and approximately 30% are not taking treatment.
This study brings together key healthcare partners, resources,
and technology to explore the impact of blockchain and crypto
rewards in addressing the major challenge in improving survival and
treatment rates of people living with HIV and AIDS
KAKAMEGA, Kenya, Sept. 26, 2022 /PRNewswire/
-- Immunify.Life, a transformative blockchain-based healthcare
ecosystem, in partnership with Masinde Muliro University of Science
and Technology (MMUST) – the premier science, technology, and
innovation university in Kenya –
has completed groundwork for a large-scale HIV/AIDS treatment
outcomes study that is now formally launched. As part of the study,
the Immunify.Life data capture and processing platform will be used
to help empower patients, communities, and entire countries using
token rewards that can improve medical regimen adherence rates in
previously lapsed HIV/AIDS patients.
The HIV/AIDS treatment outcomes study is an elegant application
of the Immunify.Life technology, and the results from the study
will contribute to the future Strategic Direction on HIV treatment
in Kenya
According to Department of Health coordinators in Kakamega
County, there were more than 1,000 patients with high viral loads
in July, which may be indicative of treatment failure. This means
that this study is not only necessary, but also timely.
Immunify.Life CEO Guy
Newing commented on the study by saying: "The
technology that we are using at Immunify.Life is designed to
address the challenges of HIV and AIDS, tuberculosis, and
vaccination programmes. Blockchain technology is the cutting edge
new frontier technology that will revolutionize healthcare in
Africa."
Dr. Mutay, the Head of the Medical School at MMUST, said:
"Our Vice Chancellor is keen on strengthening research capacity
and has championed the setting up of research teams to write
proposals in different areas. This project will therefore receive
the required administrative support. We expect that this project
can be used to touch lives and solve the problems of the
community."
Project Coordinator of the Immunify.Life MMUST Dr. Tecla
Jerotich Sum said: "Our greatness is determined by our
service and EVERY LIFE counts. We are committed to improving the
health outcomes and wellness of all people affected and infected
with HIV and AIDS. We are using science, innovation, technology,
and compassion to improve quality of care and avoid loss in the
cascade of care."
Dr. Sum continued to describe the benefits of the system by
saying "The project has critical components such as HIV and AIDS
screening, laboratory tests, treatment, follow up care, peer group
support, tracking of treatment outcomes, tracking of retention on
treatment, and enhanced paperless data. I am excited about this
project because its success will spread to the whole country and
later to the whole continent."
Immunify.Life is a complete and fully-sustainable platform that
can be used to incentivize patients, run health campaigns, and
seamlessly integrate peripheral health-related data and data
management tools for providers, patients, families, and more. By
collaborating with relevant government health ministries and
subsidiary entities, NGOs, partner health organizations, for-profit
partners, donors, and more, Immunify.Life is in the business of
unlocking the latent power and benefits of innovative technology in
the healthcare space.
Blockchain technology and cryptocurrencies are often perceived
as speculative, but inherent privacy, security, value-added
incentives, seamless collaboration, and cross-platform integration
that is possible using blockchain and cryptocurrencies would not be
possible in any other way. As such, these are innovations that have
unique use cases that Immunify.Life and its partners are exploring
for the well-being and benefit of all.
About Immunify.Life
Immunify.Life is a transformative and self-sustaining healthcare
ecosystem secured by blockchain. Its mission is to use blockchain
technology to address the world biggest health issues by
strengthening global health systems via an incentivized behavior
change system and data capture tool. It provides an all-in-one
platform and ecosystem to capture full, transparent health records
of secured patient medical information and offers the patient
direct access to personal data via a unique health identification
tag with the ability to consolidate this data to enable Big Data
for Health with a vision to empower all patients and emerging
economies with the tools to own and manage their health future and
data to collaboratively engage in the global health landscape.
About Masinde Muliro University of Science and Technology
(MMUST)
Masinde Muliro University of Science and Technology (MMUST)
is the premier science, technology, and innovation university in
Kenya. It has approximately 17,000
students across its branches, with the main campus located in
Kakamega Town. The university has a focus on international
collaboration and has previously executed agreements with Save the
Children Fund, a world-leading NGO with 25,000 dedicated staff
across 117 countries.
explainer video: https://www.youtube.com/watch?v=thy2oK3MGSA
Photo - https://mma.prnewswire.com/media/1903876/image1.jpg
Photo - https://mma.prnewswire.com/media/1903877/image2.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/immunifylife-launches-groundbreaking-blockchain-based-hivaids-treatment-outcomes-study-in-kenya-301631059.html